PRESTIGE-AF researchers, Prof Valeria Caso and Dr Fracesco Corea live-streamed (in Italian) on March 4th about the PRESTIGE-AF trial in Italy. They presented on the full operation for the study of secondary prophylaxis of cardioembolic stroke in patients suffering from atrial fibrillation and after-effects of cerebral haemorrhage. Coordinated by Prof, Valeria Caso of the Perugia Hospital with about 15 participating centres in Italy. In Umbria, the hospitals of Branca, Citta di Castello, Foligno and Perugia are in fact authorized to recruit candidates. Tune-in!
PRESTIGE-AF partner, Stroke Alliance for Europe launches Life After Stroke Series of Interactive Webinars for 2021
Stroke Alliance for Europe has launched a series of free interactive events to build the life after stroke healthcare, research and stroke survivor community, to stimulate debate, improve life after stroke care and build interest for SAFE’s 1st European Life After Stroke Forum on 12 March 2021.
The opening session on Friday 12 March 10.00-11.30 CET is titled Life after stroke: priorities, challenges and ways forward. The session would be of interest to neurologists, therapists, physicians, allied health professionals and nurses, social care practitioners and stroke survivors.
Registration is FREE and welcome to all. Register via the EventBrite event page
The event includes updates from Sweden, the UK, Ireland and Italy on people’s experiences of the impact of stroke before and during the pandemic, and how healthcare and support services have adapted to meet the challenges of post-pandemic stroke care. All attending will learn about new and creative ways of offering support such as using telemedicine and telerehabilitation and remote methods of looking after stroke survivors.
To mark World Stroke Day on 29 October, PRESTIGE-AF coordinator, Prof Roland Veltkamp spoke with the European Commission on the growing health problems and issues surrounding stroke and the work PRESTIGE-AF researchers are doing to reduce repeat strokes in patients with atrial fibrillation.
Learn more from Prof Veltkamp in his interview at the European Commission website.